A new study suggest that using CXCL9 and CXCL10-producing dendritic cells alongside immunotherapy can be a promising strategy to overcome treatment resistance and improve clinical outcomes for ...
CD8 radiomics signature to assess inter-lesion spatial heterogeneity and cold liver lesions in advanced non-small cell lung cancers treated with durvalumab. Effects of neutralization of tumor-derived ...
Real-world effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients aged ≥65 years with metastatic triple-negative breast cancer. Single cell spatial profiling for ...
In this new analysis, results showed that CCL3, CXCL8, CXCL9, and CXCL10 may be indicators of disease severity. Researchers are shedding light on serum indicators that may be associated with disease ...
Cell migration plays a major role in a wide range of biological functions. One such function includes lymphocyte trafficking, which is critical for protective immunity, but when dysregulated, may also ...
Urinary chemokines CXCL9 and CXCL10 appear to be good noninvasive biomarkers of kidney transplant rejection that can identify patients who warrant biopsy. Quantifying the inflammatory chemokines CXCL9 ...
In the July 12, 2021, issue of Nature Aging, researchers working at the Buck Institute for Research on Aging describe analysis from 1,001 immunomes of generally healthy patients correlating soluble ...
Patients with acute tubulointerstitial nephritis (AIN), a difficult-to-diagnose allergic reaction in the kidneys, show substantial increases in the protein CXCL9 in their urine, suggesting an ...
An inflammatory-aging clock called developed by Stanford University School of Medicine and the Buck Institute for Research on Aging can predict how strong your immune system will be in 10 years, when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results